Caris Life Sciences Inc.
CAI | NASDAQ
$32.40
-$1.93 (-5.62%)
Nov 2, 2026, 2:35 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.15M | -510K | 81.96M | 24.33M | -71.79M | -102.58M | -36.95M | -67.73M | -66.19M | -111.03M | 51.16M | 37.94M | 35.74M |
Depreciation & Amortization | 11.6M | 5.07M | 4.29M | 4.87M | 6.41M | 7.05M | 10.97M | 12.36M | 11.61M | 17.71M | 32.88M | 29.48M | 28.77M |
Stock-Based Compensation | 38.09M | n/a | 13.37M | 13.66M | 28.29M | 14.69M | 4.98M | 4.72M | 4.49M | 4.46M | 566K | 593K | 540K |
Other Working Capital | 8.67M | -16.38M | 29.3M | -2.31M | -25.7M | 5.09M | 15.87M | -17.83M | 1.53M | -52K | 1.13M | 30.85M | 33.65M |
Other Non-Cash Items | 30.89M | 20.03M | 4.26M | 5.49M | 45.81M | 36.19M | -16.24M | 450K | -8.72M | 16.12M | -13M | -7.44M | -22.45M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.41M | -2.27M | -940K |
Change in Working Capital | -18.08M | 8.29M | -59.1M | 14.09M | -1.44M | 13.32M | -1.69M | -19.23M | -4.12M | -1.18M | 21.6M | 27.97M | 34.14M |
Operating Cash Flow | 61.35M | 32.88M | 44.78M | 62.43M | 7.29M | -31.34M | -38.92M | -69.43M | -62.93M | -73.93M | 97.61M | 86.28M | 75.79M |
Capital Expenditures | -32.42M | -10.34M | -5.09M | -7.1M | -1.39M | -2.69M | -2.29M | -1.83M | -2.59M | -1.74M | -545.17M | -105.08M | -171.65M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -101.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 1.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 61.38M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29.82M | 21.62M | 27.54M |
Investing Cash Flow | -132.53M | -10.34M | -5.09M | -7.1M | -1.39M | -2.69M | -2.29M | -1.83M | -2.59M | 59.64M | -515.36M | -83.46M | -144.11M |
Debt Repayment | -12.81M | -40K | 3.96M | -23K | 23.84M | -22K | -21K | -26K | -30K | 199.9M | n/a | n/a | n/a |
Common Stock Repurchased | -21.36M | n/a | -91K | -16.56M | n/a | -22K | n/a | n/a | n/a | n/a | n/a | n/a | -12.79M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.41M | -7.41M | -7.4M |
Other Financial Acitivies | -3.57M | -56K | -4.33M | -4.51M | 646.1M | 1.33M | 247K | 113K | -99K | 210K | 436.22M | -4.66M | 69.82M |
Financial Cash Flow | -36.08M | 824K | 3.4M | -21.1M | 681.4M | 1.29M | 226K | 87K | -129K | 200.11M | 428.81M | -12.06M | 62.43M |
Net Cash Flow | -107.3M | 23.35M | 43.06M | 34.3M | 687.4M | -32.74M | -40.99M | -71.18M | -65.63M | 185.82M | 11.08M | -9.37M | -5.9M |
Free Cash Flow | 28.94M | 22.53M | 39.69M | 55.33M | 5.9M | -34.03M | -41.21M | -71.26M | -65.51M | -75.66M | -447.56M | -18.8M | -95.86M |
Adj. Free Cash Flow | -9.16M | 22.53M | 26.32M | 41.68M | -22.39M | -48.72M | -46.19M | -75.98M | -70M | -80.12M | -448.13M | -19.4M | -96.4M |
Maintenance CapEx | -11.6M | -5.07M | n/a | n/a | n/a | n/a | -2.29M | -1.83M | -2.59M | -1.74M | -32.88M | -29.48M | -28.77M |
Growth CapEx | -20.81M | -5.28M | -5.09M | -7.1M | -1.39M | -2.69M | n/a | n/a | n/a | n/a | -512.29M | -75.6M | -142.88M |
Owner Earnings | 49.75M | 27.81M | 44.78M | 62.43M | 7.29M | -31.34M | -41.21M | -71.26M | -65.51M | -75.66M | 64.73M | 56.8M | 47.02M |
Add to Watchlist
Select watchlists to add or remove CAI